Tiziana Life Sciences Ltd SEC filings TLSA
Tiziana Life Sciences Ltd has 492 filings in SEC EDGAR's recent list, going back to Nov 30, 2017. Its latest annual report, Form 20-F, was filed on May 1, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | May 1, 2026 | Dec 31, 2025 |
| 20-F/A | Amended annual report (foreign issuer) | May 8, 2025 | Dec 31, 2024 |
| 20-F | Annual report (foreign issuer) | May 6, 2025 | Dec 31, 2024 |
| 20-F | Annual report (foreign issuer) | May 10, 2024 | Dec 31, 2023 |
| 20-F/A | Amended annual report (foreign issuer) | Jun 13, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | Apr 26, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | May 23, 2022 | Dec 31, 2021 |
| 20-F | Annual report (foreign issuer) | May 17, 2021 | Dec 31, 2020 |
| 20-F | Annual report (foreign issuer) | Jun 17, 2020 | Dec 31, 2019 |
| 20-F | Annual report (foreign issuer) | Apr 4, 2019 | Dec 31, 2018 |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TLSA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Bermuda
- Headquarters
- London, England, United Kingdom
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1723069
- Former names
- Tiziana Life Sciences plc (until Oct 21, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.